Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Valent P (2015) Diagnosis and management of mastocytosis: an emerging challenge in applied hematology. Hematol Am Soc Hematol Educ Program 2015:98–105
2. 2016 Revision to the World Health Organization Classification of myeloid neoplasms and acute leukemia. Blood, American Society of Hematology [Internet] [cited 2019 Dec 3]. https://ashpublications.org/blood/article/127/20/2391/35255/The-2016-revision-to-the-World-Health-Organization
3. Horny H-P, Sotlar K, Sperr WR, Valent P (2004) Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge. J Clin Pathol 57(6):604–608
4. Pullarkat VA, Bueso-Ramos C, Lai R, Kroft S, Wilson CS, Pullarkat ST et al (2003) Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations. Am J Hematol 73(1):12–17
5. Wang SA, Hutchinson L, Tang G, Chen SS, Miron PP, Huh YO et al (2013) Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease (SM-AHNMD): clinical significance and comparison of chomosomal abnormalities in sm and AHNMD components. Am J Hematol 88(3):219–224